Abstract
Colorectal cancer is the third most common form of cancer worldwide leading to escalating mortality rates and mainly includes hereditary, sporadic and colitis-associated cancer development. The escalated mortality rates is due to the limited treatment options as this form of cancer is usually not easy to diagnose in its early stages and are highly invasive leading to rapid metastasis of the malignant cells to the neighbouring tissue. In order to combat this limitation several chemotherapeutic regimens are now being combined with targeted therapies after the knowledge acquired on the inevitable effects of the tumor microenvironment on the colon cancer growth and progress. The colon tumor niche mainly consists of a large mass of tumor cells along with various immune cells, inflammatory cells, tumor macrophages and fibroblasts that infiltrate the tumor as it is a site of predominant inflammation. Among cells of the microenvironment, mesenchymal stem cells (MSCs) exhibiting ability to evolve into cancer associated fibroblasts (CAFs) have recently generated a major interest in the field. The physiological state of the tumor microenvironment is closely connected to discrete steps of tumorigenesis. The colon cancer cells elicit various factors with their direct interaction with MSCs or via paracrine fashion, which modulate these cells to promote cancer instead of performing their innate function of abating cancer progression. This review intends to highlight the necessity to exploit the cellular landscape of tumor microenvironment of colon cancer and a detailed understanding of the interactions between tumor epithelial cells and their stromal/inflammatory elements will aid in future perspectives for designing therapeutic regimens targeting tumor microenvironment to improve the clinical outcome of colon cancer.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- CAFs:
-
Cancer Associated, Fibroblasts
- CC:
-
Colon Cancer
- CRC:
-
Colo Rectal Carcinoma
- ECM:
-
Extracellular Matrix
- EGF:
-
Epidermal Growth Factor
- EMT:
-
Epithelial to Mesenchymal Transition
- FAP:
-
Fibroblast Activating Protein
- HGF:
-
Hepatocyte Growth Factor
- MDSC:
-
Myeloid Derived Suppressor Cells
- MIF:
-
Migration Inhibitory Factor.
- MMP:
-
Matrix Metalo Proteinases
- MSCs:
-
Mesenchymal Stem Cells
- RANTES:
-
Regulated on activation, Normal T-cell Expressed and Secreted
- SCF:
-
Stem Cell Factor
- TAMs:
-
Tumour Associated Macrophages
- TME:
-
Tumour Microenvironment
- TNF:
-
Tumour Necrosis Factor
- VEGF:
-
Vascular Endothelial Growth Factor
References
Ali S, Suresh R, Banerjee S et al (2015a) Contribution of microRNAs in understanding the pancreatic tumor microenvironment involving cancer associated stellate and fibroblast cells. Am J Cancer Res 5(3):1251
Ali S, Dubaybo H, Brand RE, Sarkar FH (2015b) Differential expression of microRNAs in tissues and plasma co-exists as a biomarker for pancreatic cancer. J Cancer Sci Ther 7(11):336
Bahrami A, Khazaei M, Hassanian SM et al (2018) Targeting the tumor microenvironment as a potential therapeutic approach in colorectal cancer: rational and progress. J Cell Physiol 233(4):2928–2936
Balkwill FR, Capasso M, Hagemann T (2012) The tumor microenvironment at a glance. J Cell Sci 125(Pt 23):5591–5596
Bullock MD, Pickard KM, Nielsen BS et al (2013) Pleiotropic actions of miR-21 highlights the critical role of deregulated stromal microRNAs during colorectal cancer progression. Cell Death Dis 4(6):e684
Chen S, Huang EH (2014) The colon cancer stem cell microenvironment holds keys to future cancer therapy. J Gastrointest Surg 18(5):1040–1048
Chen J, Li C, Chen L (2015) The role of microvesicles derived from mesenchymal stem cells in lung diseases. Biomed Res Int 2015:985814
Colangelo T, Polcaro G, Muccillo L et al (2017) Friend or foe?: The tumour microenvironment dilemma in colorectal cancer. Biochim Biophys Acta Rev Cancer 1867(1):1–8
David H (1988) Rudolf Virchow and modern aspects of tumor pathology. Pathol Res Pract 183(3):356–364
Dong W, Li H, Zhang Y, Yang H, Guo M, Li L, Liu T (2011) Matrix metalloproteinase 2 promotes cell growth and invasion in colorectal cancer. Acta Biochim Biophys Sin 43(11):840–848
Gout S, Huot J (2008) Role of cancer microenvironment in metastasis: focus on colon cancer. Cancer Microenviron 1(1):69–83
Heslin MJ, Yan J, Johnson MR, Weiss H, Diasio RB, Urist MM (2001) Role of matrix metalloproteinases in colorectal carcinogenesis. Ann Surg 233(6):786
Ibrahim AF, Weirauch U, Thomas M, Grünweller A, Hartmann RK, Aigner A (2011) MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. Cancer Res 71(15):5214–5224. https://doi.org/10.1158/0008-5472.CAN-10-4645
Illemann M, Bird N, Majeed A et al (2006) MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases. Mol Cancer Res 4(5):293–302
Inoue T, Iinuma H, Ogawa E, Inaba T, Fukushima R (2012) Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer. Oncol Rep 27(6):1759–1764
Jiang X, Hu S, Liu Q, Qian C, Liu Z, Luo D (2017) Exosomal microRNA remodels the tumor microenvironment. PeerJ 5:e4196
Kuninty PR, Schnittert J, Storm G, Prakash J (2016) MicroRNA targeting to modulate tumor microenvironment. Front Oncol 6:3
Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA (2014) Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res 2014:1–19
Lazennec G, Lam PY (2016) Recent discoveries concerning the tumor-mesenchymal stem cell interactions. Biochim Biophys Acta Rev Cancer 1866(2):290–299
Lu J, Getz G, Miska EA et al (2005) MicroRNA expression profiles classify human cancers. Nature 435(7043):834
Melzer C, Yang Y, Hass R (2016) Interaction of MSC with tumor cells. Cell Commun Signal 14(1):20
Mohammadi A, Mansoori B, Baradaran B (2016) The role of microRNAs in colorectal cancer. Biomed Pharmacother 84:705–713
O’Malley G, Heijltjes M, Houston AM et al (2016) Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response? Oncotarget 7(37):60752
Peddareddigari VG, Wang D, DuBois RN (2010) The tumor microenvironment in colorectal carcinogenesis. Cancer Microenviron 3(1):149–166
Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19(11):1423–1437
Rhee KJ, Lee J, Eom Y (2015) Mesenchymal stem cell-mediated effects of tumor support or suppression. Int J Mol Sci 16(12):30015–30033
Ribatti D, Mangialardi G, Vacca A (2006) Stephen Paget and the ‘seed and soil’theory of metastatic dissemination. Clin Exp Med 6(4):145–149
Sansom SE, Nuovo GJ, Martin MM, Kotha SR, Parinandi NL, Elton TS (2010) miR-802 regulates human angiotensin II type 1 receptor expression in intestinal epithelial C2BBe1 cells. Am J Physiol Gastrointest Liver Physiol 299(3):G632–G642
Schee K, Fodstad Ø, Flatmark K (2010) MicroRNAs as biomarkers in colorectal cancer. Am J Pathol 177(4):1592–1599
Strubberg AM, Madison BB (2017) MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications. Dis Model Mech 10(3):197–214
Tauriello DV, Batlle E (2016) Targeting the microenvironment in advanced colorectal cancer. Trends Cancer 2(9):495–494
Wang B, Shen ZL, Gao ZD, Zhao G, Wang CY, Yang Y, Zhang JZ, Yan YC, Shen C, Jiang KW, Ye YJ (2015) MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP 4K4/c-Jun/MDM2 signaling pathway. Cell Cycle 14(7):1046–1058
Wang M, Zhao J, Zhang L et al (2017) Role of tumor microenvironment in tumorigenesis. J Cancer 8(5):761
Xu K, Chen Z, Qin C, Song X (2014) miR-7 inhibits colorectal cancer cell proliferation and induces apoptosis by targeting XRCC2. Onco Targets Ther 7:325
Zhang H, Li M, Han Y, Hong L, Gong T, Sun L, Zheng X (2010) Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma. Dig Dis Sci 55(9):2545–2551
Zhang Y, Guo L, Li Y, Feng GH, Teng F, Li W, Zhou Q (2018) MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer. Mol Cancer 17(1):1
Zucker S, Vacirca J (2004) Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 23(1–2):101–117
Acknowledgement
The authors are thankful to Chettinad Academy of Research and Education for providing the infrastructural support and to SERB, DST, Govt. of India for providing the financial support. The authors are thankful to Mr. Jaganth Arunachalam for technical help in formulating the table.
Funding
This work was supported fully by the grants sanctioned to Dr. Antara Banerjee (PI) from the SERB-DST Govt. of India with the sanction file no ECR/2017/001066.
Disclosure of Interest
The authors report no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Banerjee, A. et al. (2019). Role of Tumor Specific niche in Colon Cancer Progression and Emerging Therapies by Targeting Tumor Microenvironment. In: Turksen, K. (eds) Cell Biology and Translational Medicine, Volume 13. Advances in Experimental Medicine and Biology(), vol 1341. Springer, Cham. https://doi.org/10.1007/5584_2019_355
Download citation
DOI: https://doi.org/10.1007/5584_2019_355
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-79057-8
Online ISBN: 978-3-030-79058-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)
